Albrecht Fleckenstein
From Wikipedia, the free encyclopedia
German pharmacologist and physiologist
Albrecht Fleckenstein (3 March 1917 – 4 April 1992) was a German pharmacologist and physiologist best known for his discovery of calcium channel blockers.[1][2]
Albrecht Fleckenstein was born on 3 March 1917 in Aschaffenburg, Germany. He received his medical training in Würzburg and Vienna. In 1964, Fleckenstein reported on the inhibitory actions of prenylamine and verapamil on the physiological process of excitation–contraction coupling. This contributed to his discovery of calcium antagonists.[1]
Awards
In 1986, Fleckenstein received the Ernst Jung Prize, awarded annually for excellence in biomedical sciences.[3] In 1991, he also received the Albert Einstein World Award of Science.
References
- 1 2 Hurst, J. Willis; Fye, W. Bruce; Acierno, Louis J.; Worrell, L. Timothy (1 December 2004). "Albrecht Fleckenstein: Father of calcium antagonism". Clinical Cardiology. 27 (12): 710–711. doi:10.1002/clc.4960271213. PMC 6654477. PMID 15628117.
- ↑ Nayler, Winifred G. (1993). "Albrecht Fleckenstein". Cardiovascular Drugs and Therapy. 7 (1): 183. doi:10.1007/BF00878328. S2CID 8321045.
- ↑ "All Laureates". Ernst Jung Prize. Retrieved 2 September 2013.
| 1980s |
|
|---|---|
| 1990s |
|
| 2000s |
|
| 2010s |
|
